Back
Inovio Pharmaceuticals Quote, Financials, Valuation and Earnings
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
19
INO
Inovio Pharmaceuticals
Last Price:
4.98
Seasonality Move:
12.7%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.Inovio Pharmaceuticals Price Quote
$4.98
+0.02 (+0.4%)
(Updated: November 14, 2024 at 12:05 PM ET)
Inovio Pharmaceuticals Key Stats
Sell
19
Inovio Pharmaceuticals (INO)
is a Sell
Day range:
$4.94 - $5.26
52-week range:
$4.20 - $14.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.38%
Volume:
610.4K
Avg. volume:
312.1K
1-year change:
18.1%
Market cap:
$133.7M
Revenue:
$832K
EPS:
$-5.11
How Much Does Inovio Pharmaceuticals Make?
Data Unavailable
Is Inovio Pharmaceuticals Growing As A Company?
-
What Is Inovio Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.55% -
What Is Inovio Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Inovio Pharmaceuticals Stock Price Performance
-
Did Inovio Pharmaceuticals Stock Go Up Last Month?
Inovio Pharmaceuticals share price went down by -13.74% last month -
Did INO's Share Price Rise Over The Last Year?
INO share price rose by 18.1% over the past 1 year
What Is Inovio Pharmaceuticals 52-Week High & Low?
-
What Is Inovio Pharmaceuticals’s 52-Week High Share Price?
Inovio Pharmaceuticals has traded as high as $14.75 over the past 52 weeks -
What Is Inovio Pharmaceuticals’s 52-Week Low Share Price?
Inovio Pharmaceuticals has traded as low as $4.20 over the past 52 weeks
Inovio Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Inovio Pharmaceuticals?
-
How Much Debt Does Inovio Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Inovio Pharmaceuticals Have?
Cash and short term investments quarterly total is $110.4M -
What Is Inovio Pharmaceuticals’s Book Value Per Share?
Book value per share is 3.73
Is Inovio Pharmaceuticals Cash Flow Positive?
-
What Is INO Cash Flow From Operations?
Cash flow from operations (TTM) is -$112.4M -
What Is Inovio Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $24.2M -
What Is Inovio Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $69.8M
Inovio Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
INO return on invested capital is -91.32% -
What Is Inovio Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -70.72% -
What Is INO Return On Equity?
ROE is a measure of profitability and is -98.72%
Inovio Pharmaceuticals Earnings Date & Stock Price
-
What Is Inovio Pharmaceuticals's Stock Price Today?
A single share of INO can be purchased today for 4.96 -
What Is Inovio Pharmaceuticals’s Stock Symbol?
Inovio Pharmaceuticals trades on the nasdaq under the ticker symbol: INO -
When Is Inovio Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Inovio Pharmaceuticals is scheduled on November 14, 2024 -
When Is INO's next ex-dividend date?
Inovio Pharmaceuticals's next ex-dividend date is May 1, 2020 -
How To Buy Inovio Pharmaceuticals Stock?
You can buy Inovio Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Inovio Pharmaceuticals Competitors
-
Who Are Inovio Pharmaceuticals's Competitors?
Below is a list of companies who compete with Inovio Pharmaceuticals or are related in some way:
Inovio Pharmaceuticals Dividend Yield
-
What Is INO Dividend Yield?
Inovio Pharmaceuticals’s dividend yield currently is 0% -
What Is Inovio Pharmaceuticals’s Payout Ratio?
Inovio Pharmaceuticals’s payout ratio is 0% -
When Did Inovio Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 14, 2024 -
What Is Inovio Pharmaceuticals’s Dividend Per Share?
Inovio Pharmaceuticals pays a dividend of $0.00 per share
Inovio Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -8.02% |
| Revenue: | -55.41% | -17.07% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 15.75 |
| Upside from Last Price: | 217.54% |